Study of community-acquired pneumonia: Incidence, patterns of care, and outcomes in primary and hospital care

Journal of Infection

Volumn 61, Issue 5, 2010, Pages 364-371

  Capelastegui, Alberto ^a   España, Pedro P ^a   Bilbao, Amaia ^b   Gamazo, Julio ^a   Medel, Federico ^c   Salgado, Juan ^c   Gorostiaga, Iñaki ^c   Esteban, Cristobal ^a   Altube, Lander ^a   Gorordo, Inmaculada ^a   Quintana, Jose M ^a  

^a HOSPITAL DE GALDAKAO   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c General Practice Comarca Interior   (Spain)

Author keywords

Epidemiology; Management; Pneumonia

Indexed keywords

BETA LACTAM ANTIBIOTIC; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; DAILY LIFE ACTIVITY; FEMALE; HEALTH CARE MANAGEMENT; HOME CARE; HOSPITAL CARE; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; FEMALE; HOSPITALIZATION; HOSPITALS, TEACHING; HUMANS; INCIDENCE; LENGTH OF STAY; MALE; MIDDLE AGED; PNEUMONIA; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX; SPAIN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78149360198     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2010.07.015     Document Type: Article

References (35)

1. Marrie T.J. Community-acquired pneumonia. Clin Infect Dis 1994, 18:501-515.
2. Gleason P.P., Kapoor W.N., Stone R.A., et al. Medical outcomes and antimicrobial cost with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia. JAMA 1997, 278:32-39.
3. Woodhead M.A., Macfarlane J.T., McCraken J.S., et al. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987, 1:671-674.
4. Jokinen C., Heiskanen L., Juvonen H., et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol 1993, 137:977-988.
5. Macfarlane J.T., Colville A., Guion A., et al. Prospective study of aetiology and outcome of adult lower respiratory tract infections in the community. Lancet 1993, 341:511-514.
6. Almirall J., Bolibar I., Vidal J., et al. Epidemiology of community-acquired pneumonia in adults: a population-based study. Eur Respir J 2000, 15:757-763.
7. Garibaldi R.A. Epidemiology of community-acquired respiratory tract infections in adults: incidence, etiology, and impact. Am J Med 1985, 78:32-37.
8. Benson V, Marano MA. Current estimates from National Health Interview Survey, 1993. Vital & Health Statistics Series 10: Data from the National Health Survey. (189): 13-5; 1994.
9. Thomsen R.W., Riis A., Norgaard M., et al. Rising incidence and persistently high mortality of hospitalized pneumonia: a 10-year population-based study in Denmark. J Intern Med 2006, 259:410-417.
10. Kaplan V., Angus D.C., Griffin M.F., et al. Hospitalized community-acquired pneumonia in the elderly. Am J Respir Crit Care Med 2002, 165:766-772.
11. Lim W.S., Macfarlane F.T., Boswell T.C.J., et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 2001, 56:296-301.
12. Espana P.P., Capelastegui A., Quintana J.M., et al. A prediction rule to identify allocation of inpatient care in community-acquired pneumonia. Eur Respir J 2003, 21:695-701.
13. Instituto Vasco de Estadística.Poblational study Available at:. http://www.eustat.es/.
14. Lim W.S., Van der Eerden M.M., Laing R., et al. Defining community-acquired pneumonia severity presentation to hospital: an international derivation and validation study. Thorax 2003, 58:377-382.
15. Alfageme I., Aspa J., Bello S., et al. Grupo de Estudio de la Neumonia Adquirida en la Comunidad. Area de Tuberculosis e Infecciones Respiratorias (TIR)-SEPAR. Guidelines for the diagnosis and management of community-acquired pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). Arch Bronconeumol 2005, 41:272-289.
16. Mandell L.A., Wunderink R.G., Anzueto A., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia. Clin Infect Dis 2007, 44:S27-72.
17. Levy M.M., Fink M., Marshall J.C., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31:1250-1256.
18. Hanley J.A., McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982, 143:29-36.
19. Hanley J.A., McNeil B.J. A method of comparing areas under receiver operating characteristic curves derived from the same cases. Radiology 1983, 148:839-843.
20. Foy H.M., Kenny G.E., Cooney M.K., et al. Long-term epidemiology of infections with mycoplasma pneumoniae. J Infect Dis 1979, 139:681-687.
21. Foy H.M., Cooney M.K., Allan I., et al. Rates of pneumonia during influenza epidemics in Seattle, 1964 to 1975. JAMA 1979, 241:253-258.
22. Barker W.H., Mullooly J.P. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol 1980, 112:798-813.
23. Glezen W.P. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 1982, 4:25-44.
24. Sobradillo V., Zalacain R., Capelastegui A., et al. Antibiotic treatment in pneumonia due to Q fever. Thorax 1992, 47:276-278.
25. Sobradillo V., Ansola P., Baranda F., et al. Q fever pneumonia: a review of 164 community-acquired cases in the Basque country. Eur Respir J 1989, 2:263-266.
26. Marrie T.J., Peeling R.W., Fine M.J., et al. Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. Am J Med 1996, 101:508-515.
27. Fantin B., Aubert J.P., Unger P., et al. Clinical evaluation of the management of community-acquired pneumonia by General Practitioners in France. Chest 2001, 120:185-192.
28. Woodhead M., Blasi F., Ewig S., et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005, 26:1138-1180.
29. Malcolm C., Marrie T.J. Antibiotic therapy for ambulatory patients with community-acquired pneumonia in an emergency department setting. Arch Intern Med 2003, 163:797-802.
30. Arnold F.W., Summersgill J.T., Lajoie A.S., et al. A Worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med 2007, 175:1086-1093.
31. Menendez R., Torres A., Zalacain R., et al. Guidelines for the treatment of community-acquired pneumonia. Predictors of adherence and outcome. Am J Respir Crit Care Med 2005, 172:757-762.
32. Mortensen E.M., Restrepo M., Anzueto A., et al. Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia. Am J Med 2004, 117:726-731.
33. Aspa J., Rajas O., Rodriguez de Castro F., et al. Drug-resistant pneumococcal pneumonia: clinical relevante and related factors. Clin Infect Dis 2004, 38:787-798.
34. Zalacain R., Talayero N., Achotegui V., et al. Community acquired pneumonia. Reliability of the criteria for deciding ambulatory treatment. Arch Bronconeumol 1997, 33:74-79.
35. Bjerre L.M., Verheij T.J., Kochen M.M. Antibiotics for community acquired pneumonia in adult outpatients. Cochrane Database Syst Rev 2004, 2:CD002109.